The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...
The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...
A temporary heart pump manufactured by Massachusetts-based Abiomed prompted a US Food and Drug Administration letter to health care providers on Monday over an increased rate of mortality. The letter ...
Supira Medical has raised $120 million to complete the clinical development of its temporary heart pump, designed for patients undergoing high-risk cardiac procedures or suffering from shock. The ...
ALBUQUERQUE, N.M. (KRQE) – Presbyterian Heart and Vascular Care is participating in an international study to learn how a heart pump may help heart attack patients who experience a life-threatening ...
Abiomed, also now known as Johnson & Johnson MedTech, issued a recall for its Impella RP with SmartAssist and Impella RP Flex with SmartAssist heart pumps due to safety concerns. The recall involves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results